Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation – treatment with anti-D immunoglobulin

被引：0

作者：

SJ Lee

W Hallowell Churchill

A Konugres

DG Gilliland

JH Antin

机构：

[1] Brigham and Women’s Hospital,Department of Medicine, Division of Hematology/Oncology

[2] Harvard Medical School,Department of Medicine

[3] Brigham and Women’s Hospital,undefined

[4] Blood Bank,undefined

[5] Harvard Medical School,undefined

来源：

Bone Marrow Transplantation | 1997年 / 19卷

关键词：

idiopathic thrombocytopenic purpura; bone marrow transplantation; anti-D immunoglobulin; chronic graft-versus-host disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A 38-year-old man developed idiopathic thrombocytopenic purpura (ITP) 8 months following allogeneic BMT while being treated for cGVHD with corticosteroids and tacrolimus (FK506). He received two courses of high-dose intravenous immunoglobulin (IvIG) which resulted in transient improvement. A single dose of intravenous anti-D immunoglobulin induced a durable response. Anti-D immunoglobulin is better tolerated, less complicated to administer, and less expensive than a course of IvIG.

引用

页码：173 / 174

页数：1